Showing 61 - 80 results of 5,853 for search '"MD4"', query time: 0.17s Refine Results
  1. 61
  2. 62
  3. 63
  4. 64
  5. 65
  6. 66
  7. 67
  8. 68
  9. 69
  10. 70
  11. 71
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76

    Specific Nutrient Intake Via Diet and/or Supplementation in Relation to Female Stress: A Cross-Sectional Study by Delia McCabe, Jana Bednarz, Craig Lockwood, Timothy H. Barker

    Published 2020-08-01
    “…7.97 to 1.29), linoleic acid (MD?=??4.08, 95% CI?=??8.97 to 0.82), ?-linolenic acid (MD?…”
    Get full text
    Article
  17. 77

    Legal Education-Informed Cognitive Behavioural Therapy (LiCBT) to improve victims’ confidence in the Nigerian police: a single-arm mixed method feasibility intervention study by Tarela Juliet Ike, Dung Ezekiel Jidong, Evangelyn Ebi Ayobi

    Published 2024-12-01
    “…Findings also showed reduced depression from baseline (Md = 4.00) to end of intervention (Md = 1.00) with z = −4.061 and at 3 months (Md = 1.00) with z = −4.142. …”
    Get full text
    Article
  18. 78

    Effects of traditional Chinese exercises on cardiac rehabilitation in patients with myocardial infarction: a meta-analysis of randomized controlled trials by Jingfang Zhang, Jieqiong Weng, Mengfei Yuan, Xingchen Shen, Yayi Weng, Xiaoxu Shen

    Published 2023-10-01
    “…N-terminal pro-brain natriuretic peptide (NT-proBNP) in the TCE group were lower than the control group (MD = −96.34, 95%CI: −140.69 ∼−51.98, P < 0.00001, I2 = 96%), the left ventricular ejection fraction (LVEF) in the TCE group was higher than the control group (MD = 4.58, 95%CI: 3.28–5.88, P < 0.00001, I2 = 79%), the left ventricular end diastolic dimension (LVDD) in TCE group was lower than the control group (MD = −3.83, 95%CI: −5.27 ∼−2.38, P < 0.00001, I2 = 94%), the left ventricular end systolic diameter (LVESD) in TCE group was lower than the control group (MD = −2.17, 95%CI: −4.10 ∼−0.24, P < 0.00001, I2 = 96%), The 6-minute walk test (6MWT) in the TCE group was higher than the control group (MD = 69.60, 95%CI: 34.59–104.60, P < 0.00001, I2 = 99%), the oxygen uptake (VO2) in the TCE group was higher than the control group (MD = 4.38, 95%CI: 2.25–6.51, P < 0.00001, I2 = 94%), the 36-item short form survey (SF-36) in the TCE group was higher than the control group (MD = 13.34, 95%CI: 9.25–17.42, P = 0.008, I2 = 75%), the Hamilton Anxiety Scale (HAMA) in the TCE group was lower than the control group (MD = −4.34, 95%CI: −5.18 ∼−3.50, P = 1.00, I2 = 0%), the Hamilton Depression Scale (HAMD) in the TCE group was lower than the control group (MD = −3.48, 95%CI: −5.35 ∼−1.61, P = 0.0002, I2 = 88%), the incidence of major adverse cardiac events (MACEs) in the TCE group was lower than the control group (RR = 0.31, 95%CI: 0.20–0.47, P = 0.52, I2 = 0%). …”
    Get full text
    Article
  19. 79

    Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musc... by Susanne Pettersson, Elena Elefante, Simona Rednic, Jette Primdahl, Caroline Feldthusen, Pedro Machado, Kirsten Hoeper, Valentin Ritschl, Eduardo José Ferreira Santos, Fernando Estévez-López, Peter Böhm, Rinie Geenen, Ilaria Bini, Tanja Thomsen, Mart van de Laar, Eduardo Santos, Claire Harris, Raj Amarnani, Marie Urban, Bayram Farisogullari, Corinna Elling-Audersch, Marta Redondo, Rhys Hayward, Deirdre Conolly

    Published 2023-11-01
    “…Golimumab (n=2 RCTs; 24 weeks: MD=−5.27, p<0.001), baricitinib (n=2 RCTs; 24 weeks: MD=−4.06, p<0.001), sarilumab (n=2 RCTs; 24 weeks: MD=−3.15, p<0.001), tocilizumab (n=3 RCTs; 24 weeks: MD=−3.69, p<0.001) and tofacitinib (n=3 RCTs; 12 weeks: MD=−4.44, p<0.001) were also superior to placebo in reducing fatigue in RA. …”
    Get full text
    Article
  20. 80